Akso Health Group AHG
Set alert
1.26 USD -0.07 -5.26%
At close · Oct 30
1.26 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.24 Day range 1.27
0.691 52-week range 2.50
- YTD
- -23.17%
- 1 year
- -24.55%
- Open
- 1.25
- Prev close
- 1.33
- Mkt cap
- 1.08B
- Vol
- 4.90K
- Avg vol
- 109.39K
- EPS
- -0.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.24
- High
- 1.27
- Forward P/E
- 0.00
- Beta
- -1.00
- Short ratio
- 0.25
- Inst. own
- 0.03%
- Dividend
- 0.00
- Ex-div date
- Jul 31, 2018
- Earnings
- Aug 14, 2025
- 50-d avg
- 1.01
- 200-d avg
- 1.51
- 1y target
- 0.00
5D chart
Signals (11)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 4:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 4 days ago |
| SMA: Bearish | Oct 27, 3:40 PM | 4 days ago |
Financial health
Altman Z-Score
73.66 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -76.0×
FY 2017 5y median -2.5× FY 2026
P/S 119×
FY 2017 5y median 9.8× FY 2026
P/B 9.1×
FY 2017 5y median 0.9× FY 2026
P/FCF -8.7×
FY 2017 5y median -0.8× FY 2026
EV/EBITDA -1012×
FY 2017 5y median 0.4× FY 2026
EV/Sales 119×
FY 2017 5y median -0.4× FY 2026
FCF Yield -11.4%
FY 2017 5y median -11.4% FY 2026
Profitability
Gross Margin -0.1%
FY 2017 5y median 5.1% FY 2026
Operating Margin -28.9%
FY 2017 5y median -108.2% FY 2026
Net Margin -135.0%
FY 2017 5y median -280.8% FY 2026
ROE -10.3%
FY 2017 5y median -15.6% FY 2026
ROIC -2.0%
FY 2017 5y median -26.5% FY 2026
ROA -9.8%
FY 2017 5y median -9.8% FY 2026
Growth (YoY)
Revenue -6.4%
FY 2017 FY 2026
Operating Income 97.6%
FY 2017 FY 2026
EPS (diluted) 93.8%
FY 2017 FY 2026
Free Cash Flow -18527.4%
FY 2017 FY 2026
Financial Health
Current Ratio 21.8×
FY 2017 5y median 14.2× FY 2026
Quick Ratio 21.7×
FY 2017 5y median 14.2× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -0.1×
FY 2017 5y median 5.8× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31